NICE Rejects Tecentriq For Small-Cell Lung Cancer In England

Uncertainties Remain Over Long-Term Effectiveness

 
• By Ian Schofield
  
Lung cancer
NICE has turned down Tecentriq for small-cell lung cancer • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe